Peritoneal carcinomatosis from unusual cancer origins: Is there a role for hyperthermic intraperitoneal chemotherapy?

Conclusion The decision to perform CCRS plus HIPEC for PC arising from unusual cancer origins remains difficult. These patients should be prospectively entered into registries of rare tumors that involve the peritoneum in order to better define indications. (Source: Journal of Visceral Surgery)

from MedWorm: Mesothelioma http://www.medworm.com/index.php?rid=157456946&cid=c_409_43_f&fid=40284&url=http%3A%2F%2Frss.sciencedirect.com%2Faction%2FredirectFile%3F%26zone%3Dmain%26currentActivity%3Dfeed%26usageType%3Doutward%26url%3Dhttp%253A%252F%252Fwww.sciencedirect.com%252Fscience%253F_ob%253DGatewayURL%2526_origin%253DIRSSSEARCH%2526_method%253DcitationSearch%2526_piikey%253DS1878788615001769%2526_version%253D1%2526md5%253D5edd7e156e05b6d516eef60643c27720